Optimisation of vitamin A dosing schedules in infancy

ISRCTN ISRCTN98554309
DOI https://doi.org/10.1186/ISRCTN98554309
Secondary identifying numbers N/A
Submission date
30/08/2005
Registration date
10/10/2005
Last edited
27/07/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Andrew Prentice
Scientific

MRC International Nutrition Group
London School of Hygiene and Tropical Medicine
London
WC1E 7HT
United Kingdom

Phone +44 (0)20 7958 8140
Email andrew.prentice@lshtm.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typePrevention
Scientific title
Study objectivesEarly high-dose vitamin A supplementation of mothers and infants improves vitamin A status and protects against mucosal infections, growth faltering and illness compared to the standard World Health Organisation (WHO) regimen.
Ethics approval(s)Not provided at time of registration.
Health condition(s) or problem(s) studiedVitamin A deficiency
InterventionEarly high dose Vitamin A schedule versus standard WHO schedule.
Intervention typeSupplement
Primary outcome measure1. Vitamin A status in mothers and infants
2. Heliobacter pylori infection in infants
3. Nasopharyngeal pneumococcal carriage in mothers and infants
4. Gut permeability in infants assessed by Dual Pugar Permeability Test (DSPT)
Secondary outcome measures1. Infant growth
2. Infant morbidity
3. Breast milk sodium-potassium ratios
4. Breast-milk oligosaccharides
Overall study start date01/09/2001
Completion date01/10/2004

Eligibility

Participant type(s)Patient
Age groupNeonate
SexBoth
Target number of participants220
Key inclusion criteriaConsenting mothers and new born infants in six villages in the West Kiang region of The Gambia.
Key exclusion criteria1. Congenital defects
2. Birthweight under 2200 g
Date of first enrolment01/09/2001
Date of final enrolment01/10/2004

Locations

Countries of recruitment

  • England
  • Gambia
  • United Kingdom

Study participating centre

MRC International Nutrition Group
London
WC1E 7HT
United Kingdom

Sponsor information

Medical Research Council (UK)
Research council

20 Park Crescent
London
W1N 4AL
United Kingdom

Phone +44 (0)20 7636 5422
Email corporate@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk
ROR logo "ROR" https://ror.org/03x94j517

Funders

Funder type

Research council

Medical Research Council (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results: 23/06/2007 Yes No